Sublingual vaccination

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Human Vaccines

• Publication date

  2011-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.7.1.13739PMID 21263223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MUCOSAL IMMUNITY AND VACCINES

  2013influential reference
• Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.

  2010cited by this paper
• Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

  2010cited by this paper
• CCR7-CCL19/CCL21-Regulated Dendritic Cells Are Responsible for Effectiveness of Sublingual Vaccination1

  2009cited by this paper
• Cholera toxin B suppresses allergic inflammation through induction of secretory IgA

  2009cited by this paper
• Enteric vaccines for the developing world: a challenge for mucosal immunology

  2009cited by this paper
• Sublingual Immunization with Nonreplicating Antigens Induces Antibody-Forming Cells and Cytotoxic T Cells in the Female Genital Tract Mucosa and Protects against Genital Papillomavirus Infection1

  2009cited by this paper
• Sublingual vaccination with influenza virus protects mice against lethal viral infection

  2008cited by this paper
• Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.

  2007cited by this paper
• Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

  2005cited by this paper
• Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines.

  2005cited by this paper
• Effect of the Menstrual Cycle on Immunological Parameters in the Human Female Reproductive Tract

  2005cited by this paper
• Allergen immunotherapy.

  2004cited by this paper
• Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.

  2004cited by this paper
• A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts 1

  2003cited by this paper
• Chemokines in Lymphocyte Trafficking and Intestinal Immunity

  2003cited by this paper
• Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System

  2003cited by this paper
• Plasma-cell homing

  2003cited by this paper
• A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.

  2002cited by this paper
• Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in Humans

  2001cited by this paper
• Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

  2000cited by this paper
• Specific-Antibody-Secreting Cells in the Rectums and Genital Tracts of Nonhuman Primates following Vaccination

  1998cited by this paper
• Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates

  1998cited by this paper
• Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.

  1997cited by this paper
• Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.

  1997cited by this paper
• The common mucosal immune system and current strategies for induction of immune responses in external secretions

  1987cited by this paper

• Harnessing mucosal immunity for protective vaccines.

  2026cites this paper
• Evaluating the use of Uromune® autovaccine in recurrent urinary tract infections: a pilot unicenter retrospective study in Reus, Spain

  2025cites this paper
• Current Evidence on Safety, Efficacy and Efficiency of Sublingual Vaccine Uromune® in Prevention of Recurrent Urinary Tract Infections: A Literature Review

  2025cites this paper
• Correlations Between Rheology, In Situ Mucosal Retention and In Vivo Immunogenicity Reveal the Potential and Limitations of Mucoadhesive Excipients for Sublingual Vaccine Delivery

  2025cites this paper
• A Narrative Review of Periodontal Vaccines: Hope or Hype?

  2025cites this paper
• Tuning Helical Peptide Nanofibers as a Sublingual Vaccine Platform for a Variety of Peptide Epitopes

  2024cites this paper
• A review on immunization of DNA vaccine

  2024cites this paper
• Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: a roadmap for scientific advancement

  2024cites this paper
• MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection

  2024cites this paper
• A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID‐19 vaccination: The good, the bad, and the ugly

  2024cites this paper
• Immune response modulation by allergen loaded into mesenchymal stem cell-derived exosomes as an effective carrier through sublingual immunotherapy.

  2023cites this paper
• The role of engineered materials in mucosal vaccination strategies

  2023cites this paper
• The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice

  2023cites this paper
• Mucosal vaccination: onward and upward

  2023cites this paper
• The effectiveness of a polyvalent antigenic complex including bacterial lysates in the treatment and prevention of rhinosinusitis against the background of acute respiratory viral infections and COVID-19 (clinical description)

  2023cites this paper
• Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice

  2022cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

  2022cites this paper
• Sublingual vaccination and delivery systems.

  2021cites this paper
• Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV

  2021cites this paper
• Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems

  2021cites this paper
• An Updated Overview of the Emerging Role of Patch and Film-Based Buccal Delivery Systems

  2021cites this paper
• Microneedles: A New Generation Vaccine Delivery System

  2021cites this paper
• Tongue as a first-line immune organ?

  2021cites this paper
• Historical Perspectives on Mucosal Vaccines

  2020cites this paper
• Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection

  2020cites this paper
• Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of the current literature and plans for the future.

  2020cites this paper
• Analysis of the Efficacy of a Sublingual Bacterial Vaccine in the Prophylaxis of Recurrent Urinary Tract Infection

  2020cites this paper
• Mucosal vaccines: Strategies and challenges.

  2020cites this paper
• Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileum

  2019cites this paper
• Mucosal Immunity in Sexually Transmitted Infections

  2018cites this paper
• Nanofibers in Mucosal Drug and Vaccine Delivery

  2018cites this paper
• Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization

  2017cites this paper
• The salivary gland as a target for enhancing immunization response

  2017cites this paper
• Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery

  2017cites this paper
• Helicobacter suis infections : host response and different vaccination strategies

  2017cites this paper
• Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates

  2017cites this paper
• New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice.

  2016cites this paper
• MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88

  2016cites this paper
• Respiratory Virus Vaccines

  2015influential citation
• Enhancing Vaccine Safety Capacity Globally: A Lifecycle Perspective.

  2015cites this paper
• An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.

  2015cites this paper
• Establishment and first characterization of a sublingual epithelial and immune cell co-culture model.

  2015cites this paper
• Enhancing vaccine safety capacity globally: A lifecycle perspective.

  2015cites this paper
• Bacillus subtilis comes of age as a vaccine production host and delivery vehicle

  2015cites this paper
• Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

  2014cites this paper
• Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.

  2014cites this paper
• Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2/B Chimera after Intranasal Delivery

  2014cites this paper
• Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects.

  2014cites this paper
• Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.

  2014cites this paper
• Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge

  2014cites this paper
• Gut Adhesive Bacillus subtilis Spores as a Platform for Mucosal Delivery of Antigens

  2014cites this paper
• Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells

  2013cites this paper
• Secretory immunity with special reference to the oral cavity

  2013cites this paper
• Toxicity and Immunogenicity of Enterotoxigenic Escherichia coli Heat-Labile and Heat-Stable Toxoid Fusion 3xSTaA14Q-LTS63K/R192G/L211A in a Murine Model

  2013cites this paper
• Secretory IgA: Designed for Anti-Microbial Defense

  2013cites this paper
• Formulation of HPV Dry Powder Wafers for Sublingual Vaccination

  2012cites this paper
• Optimizing efficacy of mucosal vaccines

  2012cites this paper
• Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers

  2012influential citation
• Mucosal antibodies in the regulation of tolerance and allergy to foods

  2012cites this paper
• Design of solid dosage forms for mucosal vaccination - Investigations on the influence of excipients on product performance

  2012cites this paper
• The mucosal vaccine quandary: Intranasal vs. sublingual immunization against influenza

  2012cites this paper
• Towards tailored vaccine delivery: needs, challenges and perspectives.

  2012cites this paper
• B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.

  2012cites this paper
• Recent progress in mucosal vaccine development: potential and limitations

  2012cites this paper
• Induction of Tolerance via the Sublingual Route: Mechanisms and Applications

  2011cites this paper
• Reproductive component vaccine developments for contraceptive and non-contraceptive uses

  2011cites this paper
• Mucosal Immunization with a Staphylococcus aureus IsdA-Cholera Toxin A2/B Chimera Induces Antigen-Specific Th2-Type Responses in Mice

  2011cites this paper
• Digital Commons

  year unknowncites this paper